BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3051% above fair value
$72.63−0.16 (-0.22%)
Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%
Bio-Techne shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Bio-Techne's shares outstanding was 157M at Jun 30, 2026. For fiscal 2026 it was 157M, down 1.7% from the year before. Over ten years it grew 0.5% a year on average. The highest annual figure on record is 164M in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 157M | -1.7% |
| FY2025 | Jun 30, 2025 | 160M | -0.7% |
| FY2024 | Jun 30, 2024 | 161M | -0.7% |
| FY2023 | Jun 30, 2023 | 162M | -1.4% |
| FY2022 | Jun 30, 2022 | 164M | +1.3% |
| FY2021 | Jun 30, 2021 | 162M | +2.7% |
| FY2020 | Jun 30, 2020 | 158M | +1.3% |
| FY2019 | Jun 30, 2019 | 156M | +2.2% |
| FY2018 | Jun 30, 2018 | 152M | +1.5% |
| FY2017 | Jun 30, 2017 | 150M | +0.5% |
| FY2016 | Jun 30, 2016 | 149M | +0.3% |
| FY2015 | Jun 30, 2015 | 149M | +0.6% |
| FY2014 | Jun 30, 2014 | 148M | +0.3% |
| FY2013 | Jun 30, 2013 | 148M | -0.3% |
| FY2012 | Jun 30, 2012 | 148M | -0.4% |
| FY2011 | Jun 30, 2011 | 149M | -0.5% |
| FY2010 | Jun 30, 2010 | 149M | -1.5% |
| FY2009 | Jun 30, 2009 | 152M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | 157M | +0.2% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | 157M | -1.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | 157M | -2.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | 156M | -3.0% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | 157M | -2.3% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | 159M | -1.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | 161M | +0.4% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | 161M | -0.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | 161M | -0.9% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | 160M | -0.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | 160M | -1.0% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | 162M | -0.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | 162M | -0.9% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | 162M | -1.4% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | 162M | -1.9% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | 162M | -1.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | 164M | -0.3% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | 164M | +0.7% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | 165M | +2.4% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | 165M | +2.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | 164M | +3.3% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | 163M | +3.1% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | 161M | +1.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | 160M | +2.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | 159M | +1.4% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | 158M | +1.5% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | 158M | +2.1% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | 157M | +1.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | 157M | +2.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | 155M | +1.9% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | 155M | +2.2% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | 155M | +2.9% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | 153M | +2.1% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | 153M | +1.7% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | 152M | +1.2% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | 151M | +0.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | 150M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | 150M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | 150M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | 150M | – |
See a number that looks wrong?